Opinion
Video
Author(s):
Bladder cancer experts discuss the evolving treatment landscape in BCG-unresponsive NMIBC and give an overview of TAR-200, an emerging therapy.
NMIBC Clinical Forums highlight novel therapies and treatment strategies
Bladder Cancer Awareness Month: Dr. Kamat highlights the state of bladder cancer care
FDA approval sought for Anktiva in papillary NMIBC
Dr. Lutz on sexual dysfunction, performance anxiety, and Peyronie's disease
The importance of federal funding in cancer research: A call to action
FDA updates in urology: March 2025